Pfizer and BioNTech have asked US regulators to make their COVID-19 vaccine available for adolescents aged 12 to 15.
The vaccine is authorized by the Food and Drug Administration for individuals 16 years old and older. The companies asked that authorization be expanded to younger teens.
In a statement issued on Friday, the companies said they plan to make similar requests worldwide in the coming days.
The vaccine showed "100 percent efficacy" and triggered a "robust antibody response" in trials with adolescents, the companies announced last month.
This is a developing story. Please check back for more updates.
Read the original article on Business Insider